GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis.

Elsa Viera SousaPedro AlvesAna M RodriguesFilipa TeixeiraJose Tavares-CostaAlexandra BernardoSofia PimentaFernando M Pimentel-SantosJoão Lagoas GomesRenata AguiarPatrícia PintoTaciana VideiraCristina CatitaHelena SantosJoana BorgesGraça SequeiraCélia RibeiroLídia TeixeiraPedro Ávila-RibeiroFernando M MartinsHelena CanhãoIain B McInnesRuy M RibeiroJoão Eurico Fonseca

Published in: Annals of the rheumatic diseases (2020)

NCT02065713.

Keyphrases

double blind
placebo controlled
clinical trial
phase iii
study protocol
hiv infected
high dose
randomized controlled trial
ulcerative colitis
rheumatoid arthritis
systemic lupus erythematosus